These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2651790)

  • 21. Bone alkaline phosphatase isoenzyme in renal osteodystrophy.
    Jarava C; Armas JR; Salgueira M; Palma A
    Nephrol Dial Transplant; 1996; 11 Suppl 3():43-6. PubMed ID: 8840311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum osteocalcin levels in primary hyperparathyroidism.
    Pietschmann P; Niederle B; Anvari A; Woloszczuk W
    Klin Wochenschr; 1991 May; 69(8):351-3. PubMed ID: 1886398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. News on biomarkers in CKD-MBD.
    Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up.
    Rothmund M; Wagner PK
    Ann Surg; 1983 Jan; 197(1):7-16. PubMed ID: 6848057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients.
    Coen G; Mazzaferro S; De Antoni E; Chicca S; DiSanza P; Onorato L; Spurio A; Sardella D; Trombetta M; Manni M
    Am J Nephrol; 1994; 14(2):106-12. PubMed ID: 8080002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program.
    Wilson RE; Hampers CL; Bernstein DS; Johnson JW; Merrill JP
    Ann Surg; 1971 Oct; 174(4):640-54. PubMed ID: 4938487
    [No Abstract]   [Full Text] [Related]  

  • 28. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Manni M; Pasquali M; Perruzza I; Sardella D; Spurio A
    Am J Nephrol; 1992; 12(4):246-51. PubMed ID: 1481872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal osteodystrophy with hyperparathyroidism: the diagnostic value of intact parathormone, alkaline phosphatase, osteocalcin and procollagen.
    Rubini G; Anelli F; Correale M; Lauriero F; Rubini D; D'Addabbo A
    J Nucl Biol Med (1991); 1994 Sep; 38(3):489-94. PubMed ID: 7865545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
    Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
    Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 34. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
    Joffe P; Hyldstrup L; Heaf JG; Pødenphant J; Henriksen JH
    Am J Nephrol; 1992; 12(6):419-24. PubMed ID: 1292341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma osteocalcin in man.
    Melick RA; Farrugia W; Quelch KJ
    Aust N Z J Med; 1985 Aug; 15(4):410-6. PubMed ID: 3878701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone metabolism in patients with functioning kidney grafts: increased serum levels of osteocalcin and parathyroid hormone despite normalisation of kidney function.
    Pietschmann P; Vychytil A; Woloszczuk W; Kovarik J
    Nephron; 1991; 59(4):533-6. PubMed ID: 1766491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Donato G; Massimetti C; Ballanti P; Bondatti F; Della Rocca C; Smacchi A; Mantazzoli F; Cinotti GA
    Adv Exp Med Biol; 1986; 208():297-303. PubMed ID: 3494388
    [No Abstract]   [Full Text] [Related]  

  • 38. [Markers of bone pain in hemodialysis patients with renal insufficiency].
    Oka F; Sagawa H; Yabe K; Okuyama A; Tachibana M; Noge T; Torizumi K; Okamoto S; Yasui M; Tuda T
    Radioisotopes; 1988 Oct; 37(10):572-5. PubMed ID: 3264410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
    Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
    Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.